Skip to main content
RPbio Inc. logo

RPbio Inc. — Investor Relations & Filings

Ticker · 314140 ISIN · KR7314140005 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2023-01-18 AGM Information
Country KR South Korea
Listing KO 314140

About RPbio Inc.

https://rpbio.co.kr/html/en/main.php

RPbio Inc. is a bio-health company specializing in the development and production of pharmaceuticals and health functional foods. Established in 1983 as a joint venture with RP Scherer, the company is a leading producer of soft capsules, leveraging extensive technological expertise. RPbio operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services that include research and development, raw material sourcing, manufacturing of finished drugs, and OEM/ODM for health supplements. The company focuses on advancing softgel technologies and offers integrated solutions, including regulatory support, to its global partners in the pharmaceutical and health sectors.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system regarding a 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). It details the agenda for an upcoming Extraordinary General Meeting, including the appointment of directors and auditors, and provides specific biographical details for the nominees. Since this document is a formal notice of a shareholder meeting and its agenda, it falls under the category of Proxy Solicitation & Information Statement (PSI), as it provides the necessary information for shareholders to make voting decisions.
2023-01-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically a decrease due to market sales) by a major shareholder (Midas No. 1 Private Equity Fund) in the company RP Bio. This type of filing is used to notify the market of significant changes in shareholding thresholds, which falls under the 'Major Shareholding Notification' category.
2023-01-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company 'Alpibio'. It details the date, location, and specific agenda items, which include the election of directors and auditors. This type of document is a standard proxy solicitation or notice of meeting, which falls under the 'Proxy Solicitation & Information Statement' category as it provides shareholders with the necessary information to vote on upcoming corporate governance matters.
2022-12-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Extraordinary General Meeting (EGM) to discuss board changes. It does not contain the full proxy materials or the meeting results, but rather serves as a formal regulatory notice of the meeting's administrative preparation. Given it is a standard regulatory announcement that does not fit into specific categories like 'DVA' (results) or 'PSI' (proxy materials), it is classified as a general regulatory filing.
2022-12-30 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of a company's representative director (CEO). It details the outgoing director, the incoming director, the reason for the change (resignation), and the date of the board resolution. This aligns perfectly with the definition for Board/Management Information (MANG).
2022-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a specific individual (Kim Nam-ki, CEO) in the company 'RP Bio'. This is a standard regulatory filing for insider trading/director dealings in the South Korean market, which corresponds to the 'Director's Dealing' category.
2022-12-19 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.